M3

N/A

Report date: 2024/12/02 11:06:01

Base Information

Drug NameM3
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionCXC chemokine receptor antagonists
TargetsCXC chemokine receptor
Therapy Area/IndicationsInflammationAutoimmune DiseasesNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesXenova Group Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesXenova Group Ltd
Active IndicationsN/A
Inactive IndicationsInflammationAutoimmune DiseasesNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A